Trademark Overview
On Friday, August 8, 2025, a trademark application was filed for TECREGEN with the United States Patent and Trademark Office. The USPTO has given the TECREGEN trademark a serial number of 79435837. The federal status of this trademark filing is APPROVED FOR PUBLICATION as of Saturday, July 11, 2026. This trademark is owned by TECregen AG. The TECREGEN trademark is filed in the Pharmaceutical Products, Medical Instrument Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:
Medical services; personalized medical diagnostic services based on nanobody technology; medical testing for the diagnosis and treatment of persons.
Pharmaceutical products for the treatment of immune deficiency by promoting thymic regeneration, medical and veterinary preparations for the treatment of immune deficiency by promoting thymic regeneration; hygiene preparations for medical use, namely, disinfectants; pharmaceutical substances and preparations, in particular nanobodies being antibodies for medical purposes; antibodies for medical purposes, namely, therapeutic antibody fragments for the treatment of autoimmune diseases; antibodies for medical purposes, namely, nanobodies used as medicinal preparations for the treatment of autoimmune and cancerous diseases; chemical and biochemical preparations for medical use, namely, for the treatment of immune deficiency by promoting thymic regeneration; antibodies for medical purposes, namely, nanobodies used as chemical preparations for medical use; thymus-regenerating biotechnological preparations for medical use; diagnostic preparations for medical use; antibodies for medical purpos...
Surgical apparatus and instruments; medical, dental and veterinary apparatus and instruments, namely, infusion and injection devices for administering biological preparations; medical instruments for administering nanobody-based agents.
Scientific and technological services, namely, research and design services in the field of biotechnology, regenerative medicine and thymus regeneration; industrial analysis of pharmaceutical and biotechnological preparations, industrial research in the field of biotechnology and regenerative medicine, and industrial design services; design, development and programming of computer software; scientific research and medical research and development of biopharmaceutical preparations for thymus regeneration and immune system restoration; research and development in the field of nanobody technology; consultancy in the field of nanobody technology research and biotechnological research; development and technical maintenance of genetic banks of antibody fragments; database design and development; Software as a Service (SaaS) services featuring software for biomedical research data; computer Platform as a Service (PaaS) services featuring computer platforms for biomedical research data; web ho...
